Tokyo Tape
Sign in
← Takeda Pharmaceutical

Quarterly report · Q2

4502.TEDINET S100PFY3
Period2022-04-01 → 2022-09-30
Filed2022-11-04
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥1.97T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥1.00T2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥3.57T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.79T2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥844.8bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥255.0bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥104.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥346.0bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥97.4bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥220.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥64.5bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥302.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥284.4bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥61.4bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥166.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥61.7bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥183.6bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥46.0bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥166.8bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥61.7bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥230.2bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥183.7bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥46.0bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥14.59Tat 2022-09-30Cons.Assets IFRS
Total assets¥13.18Tat 2022-03-31Cons.Assets IFRS
Total assets¥12.56Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.88Tat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥7.49Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥6.71Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥5.68Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥5.32Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥5.18Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥6.71Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥5.68Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥798.1bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥849.7bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥607.9bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥966.2bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥305.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.12T2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥400.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥121.9bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥103.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥267.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥658.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥107.622022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥39.772022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥147.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥117.082021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥29.242021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥106.882022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥39.482022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥145.872021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥116.42021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥29.082021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio46.0%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 750
ItemContextValueUnit
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row3Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row3Member12000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row3Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant21752000
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant21752000
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0137
Revenue IFRSPrior1YTDDuration1794423000000JPY
Revenue IFRSCurrentYTDDuration1974771000000JPY
Cost of sales IFRSPrior1YTDDuration517061000000JPY
Cost of sales IFRSCurrentYTDDuration598327000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration431854000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration480214000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration254081000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration297752000000JPY
Amortization and impairment losses on intangible assets associated with products IFRSPrior1YTDDuration205545000000JPY
Amortization and impairment losses on intangible assets associated with products IFRSCurrentYTDDuration273643000000JPY
Other operating income IFRSPrior1YTDDuration19535000000JPY
Other operating income IFRSCurrentYTDDuration13476000000JPY
Other operating expenses IFRSPrior1YTDDuration59438000000JPY
Other operating expenses IFRSCurrentYTDDuration83359000000JPY
Operating profit loss IFRSPrior1YTDDuration345979000000JPY
Operating profit loss IFRSCurrentYTDDuration254953000000JPY
Finance income IFRSPrior1YTDDuration46912000000JPY
Finance income IFRSCurrentYTDDuration75707000000JPY
Finance costs IFRSPrior1YTDDuration104940000000JPY
Finance costs IFRSCurrentYTDDuration109272000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-3525000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-1366000000JPY
Profit loss before tax IFRSPrior1YTDDuration284425000000JPY
Profit loss before tax IFRSCurrentYTDDuration220022000000JPY
Income tax expense IFRSPrior1YTDDuration100704000000JPY
Income tax expense IFRSCurrentYTDDuration53269000000JPY
Profit loss IFRSPrior1YTDDuration183721000000JPY
Profit loss IFRSCurrentYTDDuration166753000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration183648000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration166756000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration73000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration-3000000JPY
Profit loss IFRSPrior1YTDDuration183721000000JPY
Profit loss IFRSCurrentYTDDuration166753000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration117.08
Basic earnings loss per share IFRSCurrentYTDDuration107.62
Diluted earnings loss per share IFRSPrior1YTDDuration116.40
Diluted earnings loss per share IFRSCurrentYTDDuration106.88
Revenue IFRSPrior1QuarterDuration844819000000JPY
Revenue IFRSCurrentQuarterDuration1002307000000JPY
Cost of sales IFRSPrior1QuarterDuration275797000000JPY
Cost of sales IFRSCurrentQuarterDuration305445000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration212011000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass